High incidence of lymph node metastasis in major salivary gland cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 7, 2003, Pages 720-723

  Stennert, Eberhard ^a   Kisner, Dilek ^a   Jungehuelsing, Markus ^b   Guntinas Lichius, Orlando ^a   Schröder, Ursula ^a   Eckel, Hans Edmund ^c   Klussmann, Jens Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b KLINIKUM ERNST VON BERGMANN   (Germany)

^c GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEALTH CENTER; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; NECK METASTASIS; SALIVARY GLAND CANCER; SCHOOL CHILD;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SALIVARY GLAND NEOPLASMS;

EID: 0037489634     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.7.720     Document Type: Article

References (24)

1. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8:177-184.
2. Stennert E, Jungehuelsing M. Surgical treatment of the parotid gland including facial nerve reconstruction: state of the art. Laryngorhinootologie. 2001;80 (suppl):157-197.
3. Spiro RH. The management of salivary neoplasms: an overview. Auris Nasus Larynx. 1985;12(suppl 2):S122-S127.
4. Kelley DJ, Spiro RH. Management of the neck in parotid carcinoma. Am J Surg. 1996;172:695-697.
5. Ferlito A, Shaha AR, Rinaldo A, Mondin V. Management of clinically negative cervical lymph nodes in patients with malignant neoplasms of the parotid gland. ORL J Otorhinolaryngol Relat Spec. 2001;63:123-126.
6. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69:615-619.
7. Rodriguez-Cuevas S, Labastida S, Baena L, Gallegos F. Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy. Eur Arch Otorhinolaryngol. 1995;252:139-142.
8. Spiro RH, Huvos AG, Strong EW. Cancer of the parotid gland: a clinicopathologic study of 288 primary cases. Am J Surg. 1975;130:452-459.
9. Medina JE. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am. 1998;31:815-822.
10. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP. American Joint Committee on Cancer Staging Manual. 5th ed. Philadelphia, Pa: JB Lippincott; 1997.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1953;53:457-581.
12. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116:290-293.
13. Bardwill JM. Tumors of the parotid gland. Am J Surg. 1967;114:498-502.
14. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands: recent trends. Arch Otolaryngol Head Neck Surg. 1989;115:316-321.
15. Johns ME. Parotid cancer: a rational basis for treatment. Head Neck Surg. 1980;3:132-141.
16. Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, Goepfert H. Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg. 1993;119:517-520.
17. Regis DBS I, Kowalski LP, Cavalcante DAV, Flavia LA, Magrin J. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg. 2001;127:56-60.
18. Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL. Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer. 1977;40:2882-2890.
19. Spiro RH, Huvos AG, Strong EW. Acinic cell carcinoma of salivary origin: a clinicopathologic study of 67 cases. Cancer. 1978;41:924-935.
20. Scher RL, Feldman PS, Lambert PR. Oncocytic malignancy of the parotid gland. Otolaryngol Head Neck Surg. 1991;105:868-876.
21. Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001;23:705-712.
22. Robbins KT. Indications for selective neck dissection: when, how, and why. Oncology (Huntingt). 2000;14:1455-1464.
23. Bensadoun RJ, Blanc-Vincent MP, Chauvel P, Dassonville O, Gory-Delabaere G, Demard F. Malignant tumours of the salivary glands. Br J Cancer. 2001;84 (suppl 2):42-48.
24. Hocwald E, Korkmaz H, Yoo GH, et al. Prognostic factors in major salivary gland cancer. Laryngoscope. 2001;111:1434-1439.